Table:
begin	end	state
1	24	non-cytoplasmic
25	43	transmembrane
44	65	cytoplasmic
66	87	transmembrane
88	93	non-cytoplasmic
94	116	transmembrane
117	155	cytoplasmic
156	177	transmembrane
178	182	non-cytoplasmic
183	201	transmembrane
202	247	cytoplasmic
248	272	transmembrane
273	285	non-cytoplasmic
286	310	transmembrane
311	321	cytoplasmic
322	340	transmembrane
341	345	non-cytoplasmic
346	367	transmembrane
368	376	cytoplasmic
377	401	transmembrane
402	407	non-cytoplasmic
408	430	transmembrane
431	438	cytoplasmic

Input:
>BPHYT_RS20950 FitnessBrowser__BFirm:BPHYT_RS20950
MKVVEEQTLSARNPAYADTTKRSKVRYVVLSMLLAATILNYVDRSALGIVAPGLSKGLAL
DKMQMGELFAAFGLAYSIGLVPGGVLTDVLGSRVAYALSLLGWSFATLTQGLATGYHMLL
GSRLAIGALEAPAFPSNARAVTLWFPARERGFATSVYVMGQYIGTPLFTGLLLWISAAYG
WRMVFYVTGGVGILFSLFWYRVYRDPHQHASVNAAELQYINDGSTAARKPREKFDWRMAL
KLLSYRQILAICVGKFCNNTLLVFFTTWFMTYLIEARHMSMIKVGIFQALPFIGATAGIL
LAGSLSDFFIRRGVSISTARKTPLIVGTLLGASIVLVNFVESNEAVIAILTIAFFAQGVG
SMSWAAVSEIAPRQYVGLTSSITSLAANIAGVTTPLMIGYITHHTGHFYWALNLMGAICL
LGAFSYSVLLGKLSRIEL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server